Our recent research has demonstrated that CHI3L1 functions beyond a biomarker in NMO pathogenesis, revealing its role in suppressing hippocampal neurogenesis — a process that can be targeted to restore cognitive decline in NMO mouse models (15). The gene discussed is CHI3L1; the disease is neuromyelitis optica.